Microstim is developing a tissue‑maintaining, function‑preserving implantable muscle stimulator intended for muscle‑powered cardiac assistance. The implant continuously monitors stimulation loading of the muscle and counteracts therapy‑threatening overstimulation. The company raised €500K in funding to advance its program. Backers include HCS Beteiligungsgesellschaft, the Technologiefonds MV, High‑TechGruenderfonds and Fides Finanz‑Invest. Microstim intends to use the funds for European CE‑approval and the first clinical application of its system. The company is led by co‑founder and managing director Dr. Peter Klapproth. Microstim GmbH, based in Wismar, Germany, develops a tissue‑maintaining, function‑preserving implantable muscle stimulator for muscle‑powered cardiac assistance. The company’s patented stimulation system permanently monitors stimulation loading of the muscle and counteracts therapy‑threatening overstimulation. Microstim is led by co‑founder and managing director Dr. Klapproth. The product is being developed in collaboration with the Clinic of Cardiac Surgery, Lübeck, at the University Hospital Schleswig‑Holstein. The company has raised €1.5m in funding to advance the program. It intends to use the funds for development, construction and the first clinical application of the stimulator, planned in 2012.

Total raised

$3M

Funding rounds

2

Latest round

Equity

Latest activity

Sep 2013